DE69735599D1 - Ölkörper und damit assoziierte proteine als affinitätsmatrix - Google Patents

Ölkörper und damit assoziierte proteine als affinitätsmatrix

Info

Publication number
DE69735599D1
DE69735599D1 DE69735599T DE69735599T DE69735599D1 DE 69735599 D1 DE69735599 D1 DE 69735599D1 DE 69735599 T DE69735599 T DE 69735599T DE 69735599 T DE69735599 T DE 69735599T DE 69735599 D1 DE69735599 D1 DE 69735599D1
Authority
DE
Germany
Prior art keywords
associated proteins
affinity matrix
oil bodies
bodies
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69735599T
Other languages
English (en)
Other versions
DE69735599T2 (de
Inventor
Maurice Moloney
Joseph Boothe
Rooijen Gijs Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SemBioSys Genetics Inc
Original Assignee
SemBioSys Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SemBioSys Genetics Inc filed Critical SemBioSys Genetics Inc
Application granted granted Critical
Publication of DE69735599D1 publication Critical patent/DE69735599D1/de
Publication of DE69735599T2 publication Critical patent/DE69735599T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804Affinity chromatography
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G11/00Compounds of cadmium
    • C01G11/003Preparation involving a liquid-liquid extraction, an adsorption or an ion-exchange
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B1/00Preparatory treatment of cellulose for making derivatives thereof, e.g. pre-treatment, pre-soaking, activation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804Affinity chromatography
    • B01D15/3809Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
DE69735599T 1996-12-16 1997-12-05 Ölkörper und damit assoziierte proteine als affinitätsmatrix Expired - Lifetime DE69735599T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US767026 1991-09-27
US08/767,026 US5856452A (en) 1996-12-16 1996-12-16 Oil bodies and associated proteins as affinity matrices
PCT/CA1997/000951 WO1998027115A1 (en) 1996-12-16 1997-12-05 Oil bodies and associated proteins as affinity matrices

Publications (2)

Publication Number Publication Date
DE69735599D1 true DE69735599D1 (de) 2006-05-18
DE69735599T2 DE69735599T2 (de) 2006-08-31

Family

ID=25078275

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69735599T Expired - Lifetime DE69735599T2 (de) 1996-12-16 1997-12-05 Ölkörper und damit assoziierte proteine als affinitätsmatrix

Country Status (19)

Country Link
US (5) US5856452A (de)
EP (1) EP1007554B1 (de)
JP (2) JP3833719B2 (de)
KR (1) KR100421935B1 (de)
CN (1) CN1325513C (de)
AR (1) AR010780A1 (de)
AT (1) ATE321777T1 (de)
AU (1) AU739339B2 (de)
BR (1) BR9713727B1 (de)
CA (1) CA2275489C (de)
DE (1) DE69735599T2 (de)
DK (1) DK1007554T3 (de)
ES (1) ES2259193T3 (de)
HK (1) HK1025977A1 (de)
IL (1) IL130403A (de)
NZ (1) NZ336558A (de)
TW (1) TW589322B (de)
WO (1) WO1998027115A1 (de)
ZA (1) ZA9711237B (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
JP3869861B2 (ja) * 1997-05-27 2007-01-17 セムバイオシス ジェネティクス インコーポレイテッド 油体の使用法
AU772919C (en) * 1997-05-27 2004-12-16 Sembiosys Genetics Inc. Uses of oil bodies
US6599513B2 (en) 1997-05-27 2003-07-29 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US6372234B1 (en) 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US20050106157A1 (en) * 1997-05-27 2005-05-19 Deckers Harm M. Immunogenic formulations comprising oil bodies
US7585645B2 (en) 1997-05-27 2009-09-08 Sembiosys Genetics Inc. Thioredoxin and thioredoxin reductase containing oil body based products
US6761914B2 (en) 1997-05-27 2004-07-13 Sembiosys Genetics Inc. Immunogenic formulations comprising oil bodies
MXPA01005276A (es) * 1998-11-25 2002-04-24 Sembiosys Genetics Inc Cuerpos grasos como vehiculos de suministro topico para agentes activos.
DE60136928D1 (de) * 2000-06-16 2009-01-22 Sembiosys Genetics Inc Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
KR20030066732A (ko) * 2000-12-19 2003-08-09 셈비오시스제네틱스인코포레이티드 다량체 단백질의 제조 방법 및 관련 조성물
US20030167524A1 (en) * 2000-12-19 2003-09-04 Rooijen Gijs Van Methods for the production of multimeric protein complexes, and related compositions
US7098383B2 (en) * 2000-12-19 2006-08-29 Sembiosys Genetics Inc. Methods for the production of multimeric immunoglobulins, and related compositions
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
NZ532027A (en) 2001-10-10 2008-09-26 Neose Technologies Inc Remodeling and glycoconjugation of peptides
CN105131104B (zh) 2001-10-10 2018-11-16 诺和诺德公司 肽的重构和糖缀合
US6806078B2 (en) * 2002-08-27 2004-10-19 William A. Newman Substrate and method for anaerobic remediation
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US7645803B2 (en) * 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
MXPA05004278A (es) * 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20070026485A1 (en) 2003-04-09 2007-02-01 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
DE602004015980D1 (de) * 2003-06-17 2008-10-02 Sembiosys Genetics Inc Verfahren zur insulinproduktion in pflanzen
WO2004113540A1 (en) * 2003-06-18 2004-12-29 The University Of York Expression of heterologous protein
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
BRPI0412975A (pt) * 2003-08-25 2006-10-03 Foamix Ltd espuma penetrante para uso farmacêutico
WO2005030169A1 (en) * 2003-10-02 2005-04-07 Sembiosys Genetics Inc. Methods for preparing oil bodies comprising active ingredients
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US7256014B2 (en) * 2005-07-27 2007-08-14 E. I. Du Pont De Nemours And Company Method to increase hydrophobic compound titer in a recombinant microorganism
EP1934350B1 (de) * 2005-10-19 2018-04-18 Agriculture Victoria Services Pty Ltd Polyoleosine
CA2655764A1 (en) * 2006-07-11 2008-01-17 Basf Se Protein targeting to lipid bodies
WO2008032212A2 (en) * 2006-09-08 2008-03-20 Foamix Ltd. Colored or colorable foamable composition and foam
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20100063257A1 (en) * 2007-01-26 2010-03-11 Merck Serono Sa Purification of FC-TACI Fusion Proteins Using the Oilbody Technology
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) * 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
US20110020519A1 (en) * 2008-01-04 2011-01-27 Aveka, Inc. Encapsulation of oxidatively unstable compounds
WO2009089115A1 (en) * 2008-01-04 2009-07-16 Hormel Foods Corporation Encapsulation of oxidatively unstable compounds
EP2242476A2 (de) * 2008-01-14 2010-10-27 Foamix Ltd. Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
US8592555B2 (en) * 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG195555A1 (en) * 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
TWI377954B (en) * 2009-11-25 2012-12-01 Univ China Medical Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein
CN102100914A (zh) * 2010-12-21 2011-06-22 陈顺基 能靶向治疗乳癌的人造油体载体及其制备方法和应用
SG186552A1 (en) 2011-06-08 2013-01-30 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
FI20115704L (fi) 2011-07-01 2013-01-02 Teknologian Tutkimuskeskus Vtt Oy Vierasproteiinien tuoton parantaminen
US20140220217A1 (en) 2011-07-12 2014-08-07 Maraxi, Inc. Method and compositions for consumables
BR112014000614A2 (pt) 2011-07-12 2017-07-11 Maraxi Inc métodos e composições para consumíveis
JP2014520553A (ja) 2011-07-12 2014-08-25 マラキシ インコーポレイテッド 摂食可能品のための方法および組成物
US10039306B2 (en) 2012-03-16 2018-08-07 Impossible Foods Inc. Methods and compositions for consumables
ES2875952T3 (es) 2013-01-11 2021-11-11 Impossible Foods Inc Métodos y composiciones para productos de consumo
WO2014110540A1 (en) 2013-01-11 2014-07-17 Maraxi, Inc. Non-dairy cheese replica comprising a coacervate
JP6759103B2 (ja) 2014-03-31 2020-09-23 インポッシブル フーズ インコーポレイテッド ひき肉レプリカ
ES2816026T3 (es) * 2015-10-15 2021-03-31 Cargill Inc Composición que contiene oleosomas de diferente distribución de tamaños
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US20200131553A1 (en) * 2016-10-03 2020-04-30 Alcantara Research Group Inc. A chloroplast or accumulated lipid particle enriched with an oil-body protein fusion polypeptide and method for producing the same in algae
DE102017219800B4 (de) * 2017-11-08 2021-09-23 Helmholtz-Zentrum Dresden - Rossendorf E. V. Peptid-Trägermaterialien als biofunktionalisierte Sammler
AU2020242584B2 (en) 2019-03-19 2022-12-15 Unilever Ip Holdings B.V. Frozen confection
CN110776571B (zh) * 2019-11-04 2021-08-10 福建省中医药研究院(福建省青草药开发服务中心) 一种金属硫蛋白融合蛋白构建、固定化载体快速制备及其在重金属离子去除中的应用
US20240122199A1 (en) * 2021-02-26 2024-04-18 Societe Des Produits Nestle S.A. Low ph co-extraction method of preparing a stable oil body solution
CN113176362B (zh) * 2021-06-30 2021-11-19 中国农业科学院蜜蜂研究所 一种评估天然蜂花粉及发酵蜂花粉致敏性的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
US5650554A (en) * 1991-02-22 1997-07-22 Sembiosys Genetics Inc. Oil-body proteins as carriers of high-value peptides in plants
US5474925A (en) * 1991-12-19 1995-12-12 Agracetus, Inc. Immobilized proteins in cotton fiber
ATE277180T1 (de) * 1992-04-15 2004-10-15 Sembiosys Genetics Inc Öl-körper proteine als träger von hochwertigen peptiden in pflanzen
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices

Also Published As

Publication number Publication date
CN1325513C (zh) 2007-07-11
DE69735599T2 (de) 2006-08-31
AU739339B2 (en) 2001-10-11
US20030059910A1 (en) 2003-03-27
US6924363B1 (en) 2005-08-02
EP1007554A1 (de) 2000-06-14
US5856452A (en) 1999-01-05
CA2275489C (en) 2007-03-27
US7332587B2 (en) 2008-02-19
WO1998027115A1 (en) 1998-06-25
TW589322B (en) 2004-06-01
HK1025977A1 (en) 2000-12-01
BR9713727A (pt) 2000-01-25
AR010780A1 (es) 2000-07-12
ZA9711237B (en) 1998-07-06
ATE321777T1 (de) 2006-04-15
IL130403A0 (en) 2000-06-01
ES2259193T3 (es) 2006-09-16
KR20000069499A (ko) 2000-11-25
US6509453B1 (en) 2003-01-21
EP1007554B1 (de) 2006-03-29
BR9713727B1 (pt) 2009-01-13
IL130403A (en) 2005-05-17
US20030096320A1 (en) 2003-05-22
DK1007554T3 (da) 2006-05-01
NZ336558A (en) 2001-08-31
CN1245503A (zh) 2000-02-23
JP2001506241A (ja) 2001-05-15
JP2006306881A (ja) 2006-11-09
AU5220498A (en) 1998-07-15
CA2275489A1 (en) 1998-06-25
KR100421935B1 (ko) 2004-03-10
JP3833719B2 (ja) 2006-10-18

Similar Documents

Publication Publication Date Title
DE69735599D1 (de) Ölkörper und damit assoziierte proteine als affinitätsmatrix
DE69511860T2 (de) Modifizierung von clostridium-toxinen und ihre anwendung als transport proteine
DE69732700D1 (de) Sphärisches elastomerlager
ATE285827T1 (de) Neuartige affinitatsliganden und ihre verwendung
DE59405444D1 (de) Hydraulisch dämpfende Lagerbuchse
DE69725791D1 (de) Lastausgleichsgerät und -verfahren
DE69818465D1 (de) Dämpfer und ventil
DE59712592D1 (de) Substituierte phenylketoenole als schädlingsbekämpfungsmittel und herbizide
DE69838386D1 (de) Beleuchtungssystem und dessen anwendung
DE69738197D1 (de) Azolotriazine und pyrimidine
DE69422293D1 (de) Kugellager für schere und damit versehene schere
DE69535517D1 (de) Lautsprecheranordnung und ihre Stützbeine
DE59701154D1 (de) Hydraulisch dämpfendes elastomerlager
DE69429267T2 (de) Oxazoline und thiazoline als arthropodizde
DE69401389D1 (de) Kugelförmiges Lager und Montageverfahren
DE959898T1 (de) Laktoferrin varianten und verwendungen davon
DE59505427D1 (de) Lagerbuchse
DE69835831D1 (de) Verstärker und leitsungsvertsärkungsverfahren
DE69526203D1 (de) Biologische zielgerichtete mittel
DE69408593D1 (de) 4-Aryl-4-Hydroxy-Tetrahydropyrane und 3-Aryl-3-Hydroxy-Tetrahydrofurane als 5-Lipoxygenaseinhibitoren
DE19681612T1 (de) Selbstschmierender und selbstausrichtender Kolbenring
DE19709191B4 (de) Optischer Isolator und Verstärker
DE69725834D1 (de) Focalebenenmatrix und Ansteuerungsverfahren davon
FI955537A0 (fi) Fibrinolyyttiset ja hyytymistä estävät proteiinit
DE69417452T2 (de) Buchklammer und lesezeichen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition